The FDA issued 25 warning letters to telehealth companies last month over misleading claims about compounded versions of ...

They're often cheaper and easier to get than Ozempic, but doctors say compounded GLP-1 drugs come with serious risks.

Weight-loss treatments like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been life changing for many individuals seeking to manage their weight. However, shortages and high ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you're starting a weight loss journey, you might have stumbled upon tirzepatide — the drug approved by the FDA (U.S. Food and Drug ...

Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...

Americans are still buying compounded versions of Ozempic and Zepbound more than a year after federal regulators declared that shortages of those weight-loss drugs had ended, a new study says. A ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Patients are being hospitalized with severe complications after ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

June 16 (Reuters) - The U.S. Food and Drug Administration issued 25 warning letters to telehealth companies for marketing false and misleading claims about compounded versions of Eli Lilly (LLY.N), ...

When Tina Jacobson tried to get Ozempic to lose weight, her health insurance provider denied coverage because she was not diabetic. Instead of paying more than $1,000 out of pocket for the Type 2 ...

The FDA is reviewing which compounded peptides will be permitted for production by specialized pharmacies, threatening consumer access.